Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical ...

Presented data at EADV supporting potential of ESK-001 as differentiated oral treatment in immune-mediated diseases through maximal TYK2 inhibition – – Continued to advance three clinical programs, ...

Both body creams and lotions hydrate skin, but they have a few key differences. The main is consistency. Here’s how to tell ...

Living in places with more air pollution raises the risk of eczema, a chronic condition that causes dry, itchy and inflamed ...

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

A dermatophyte known as Trichophyton mentagrophytes genotype VII (TMVII) has been identified as the cause of an emerging ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...

According to a study published in Biomaterials Advances, scientists at the University of Copenhagen have developed a patch ...

Some people come home from a beach vacation and notice their skin looks clear and glowy. It's not their imagination. Unlike ...

I used to have thick, black long hair which was 24 inches." Emmy said her scalp was engulfed in psoriasis and she told her ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...